English
Español
العربية
Bahasa Indonesia
Bahasa Melayu
Tiếng Việt
ภาษาไทย
Русский язык
Français
Italiano
Turkish
Português
日本語
한국어
简中
繁中
[CSL Assesses Potential Tariff Exemptions For U.s.-made Drugs In China] Australia's CSL Ltd Is Evaluating Whether Its U.s.-manufactured Drugs, Such As Human Albumin Used In Surgery, Will Be Exempted From The 125% Tariffs China Imposed On U.S. Goods. Reports Indicate China Is Granting Tariff Exemptions On Select U.S. Imports, Potentially Including Pharmaceuticals, And CSL Is Seeking To Determine If Its Critical Medicines Qualify. CSL Is Also Working To Diversify Its Global Supply Chain For China.
Quick access to 24/7
Quick access to more editor-selected real-time news
Exclusive video for free
FastBull VIPject team is dedicated to create exclusive videos
Follow More Symbols
You can add more symbols to your watchlist.
More comprehensive macro data and economic indicators
More comprehensive historical data on indicators to help analyze macro markets
Member-only Database
Comprehensive forex, commodity, and equity market data